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SUMMARY
Since 2000, the expansion of Sylvatic Yellow Fever (YF) has been observed in the southeast of Brazil, being detected in areas 
considered silent for decades. Epizootics in non-human primates (NHPs) are considered sentinel events for the detection of human 
cases. It is important to report epizootic events that could have impact on the conservation status of susceptible species. We describe 
the epizootics in NHPs, notified in state of São Paulo, Brazil, between September 2008 to August 2009. Ninety-one epizootic events, 
involving 147 animals, were reported in 36 counties. Samples were obtained from 65 animals (44.2%). Most of the epizootics (46.6%) 
were reported between March and April, the same period during which human cases of YF occurred in the state. Biological samples 
were collected from animals found dead and were sent to Instituto Adolfo Lutz, in São Paulo. Two samples, collected in two counties 
without an indication for YF vaccination, were positive for the virus. Another 48 animals were associated with YF by clinical-
epidemiological linkage with laboratory confirmed cases. Because the disease in human and NHPs occurred in the same period, the 
detection of the virus in NHPs did not work as sentinel, but aided in the delineation of new areas of risk.
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INTRODUCTION
The Non Human Primate (NHP) species diversity on the Neotropics 
is currently estimated at 199 species and sub-species32. According to a 
IUCN (International Union for Conservation of Nature) list of threatened 
species19, 40 out of 56 species of the Platyrrhini parvorder that exist in 
Brazil3, are listed as vulnerable, threatened or critically threatened. The 
main conservational threats faced by these NHP species, includes: loss 
and fragmentation of the habitat, predatory hunting and illegal wildlife 
trade3. 
Although no primate species is included in the list of 54 mammal 
species that have infectious diseases as the greatest threat for their 
conservation, outbreaks have impacted NHP populations in several 
regions of the world3,10,15,35, especially in Panama, Trinidad and Tobago, 
Colombia and Brazil. Historical evidences in Central and South America 
support the idea that NHP populations have been severely affected by 
Yellow Fever (YF) epizootics3,7,31. Moreover, the presence of antibodies 
against YF, in wildlife NHPs seems to be a relatively common finding20,36. 
NHPs are considered sylvatic hosts of the yellow fever virus (YFV) in 
Africa and in the Americas. 
In the African continent, NHPs seem to be more resistant to virus 
infection and are rarely threatened by the disease36. This may allow the 
quick renewal of the NHP population, facilitating the maintenance of the 
virus in the area and shortening inter-epidemic periods5,36. 
All neotropical NHP species are susceptible to the disease. 
Serological responses, clinical illnesses and spontaneous deaths 
are described in the Alouatta spp., as well as, in Callitrichidae and 
Pitheciidae species1,14,27,29,30. The primates of Aotus genus are susceptible 
too, but due to their nocturnal habits, they have limited exposure to the 
virus27. The genera Cebus, Sapajus, Ateles and Saimiri, have been shown 
to be more resistant, although RICHTER et al.30 have reported severe 
illness in Saimiri.
In the Amazon region, where the YF is considered endemic, the 
disease shows a cyclic dynamic, causing outbreaks in humans and NHPs 
at intervals varying between seven and fourteen years8. According to some 
authors13,36, this interval would be the time required for the renewal of 
the susceptible NHP populations.
The occurrence of sylvatic yellow fever (SYF) in Brazil, was 
restricted, until 2000, to the North and Middle-West regions of the 
country23,24. However, in the outbreaks that occurred in 2000/2003 
period, a geographic expansion of YFV to the southeast was observed 
and detected in areas previously free from its circulation for decades, 
thus forcing a redefinition of risk areas26. 
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More recently, in 2008-2009, outbreaks of the disease were detected 
in the Brazilian states of São Paulo18,25,26, Paraná25 and Rio Grande do 
Sul25, affecting both humans and NHPs. Twenty-eight autochthonous 
human cases were detected, in the state of São Paulo, between 2008 and 
200913,18,25,26. The disease has also been identified in NHPs in the Province 
of Missiones, Argentina14.
Epizootic events involving YF are considered sentinel for the 
detection of human cases of the disease. The Brazilian Ministry of Health 
created the Non-Human Primates Epizootic Events Surveillance System 
in 1999, which was incorporated into the Yellow Fever Surveillance 
System23. This system was established in the state of São Paulo in 2003 
and detected the first epizootic event caused by YF in February, 200826.
The lack of information on the impact of infectious diseases on NHP 
populations, and the rising threats for Brazilian NHP species, stresses 
the importance of reporting these events. The purpose of this paper is 
to describe the epizootics, reported to the NHP Epizooties Surveillance 
System in the state of São Paulo, between September 2008 till August 
2009, and, also to show how this analysis was important for supporting 
an evidence-based public-health decision-making process to guide actions 
in YF outbreak emergency situations. The article also discusses the 
possible role played by different primate species in the eco-epidemiology 
of YF in Brazil.
MATERIALS AND METHODS
Study Area: The study was conducted in the state of São Paulo, 
Brazil, which is composed of 645 counties, occupies an area of 
approximately 248,196,960 km2 , and has 41,262,199 inhabitants, 
concentrated mainly in the coastal zone16. Currently, the state has 
429 counties situated in the endemic area for YF and 216 in the non-
endemic one. This is a descriptive study encompassing events between 
September 2008 and August 2009. The NHPs death notifications to the 
Non Human epizootics Surveillance System / Public Health Department 
from the state of São Paulo, were used as database. The notifications 
were spontaneously made by the resident population to the municipal 
epidemiological surveillance authorities that provided a technician for 
the collection of biological samples, when possible.
Case definitions: The case definitions were created following the 
Guide for Surveillance of Epizootics in Non-Human Primates/Brazil 
Ministry of Health23.
YF suspected cases or suspected epizootic events: Any event 
involving death (including skin and bones found) or clinical illness, of 
at least one non human primate, whose cause was inconclusive, in any 
part of the state of Sao Paulo.
YF laboratorial confirmed cases: Suspected cases that showed 
positive laboratorial results for YF, by any of the laboratorial techniques 
cited in the study.
YF confirmed cases by clinical-epidemiological linkage: Suspected 
cases, whose sample collection was not possible, found within a radius 
of 30 km from a place with laboratorial confirmed YFV circulation up 
to within 30 days of a YF confirmed event. 
Sample collection: Monkeys found dead, but still in a suitable state 
of preservation for the study, were submitted to necropsy for the removal 
of liver, spleen, kidney, heart, lung, and intra-cardiac blood. The samples 
were sent to Instituto Adolfo Lutz, in Sao Paulo County. Animals found 
in an advanced level of autolysis (longer than 24 hours after death) were 
excluded from the study.
Laboratory diagnosis: All samples were analyzed by one or more 
of these methods: virus isolation (in mice and/or cell culture), indirect 
immunofluorescence, RT-PCR and sequencing, histopathology, and 
immunohistochemistry.
Virus isolation in mice: Samples of blood, and tissues were 
inoculated for isolation of the virus in Swiss mice, 1-3 days old. Samples 
of liver and brain were inoculated separately, and the other viscera were 
processed in a mixed suspension. The tissues were macerated, suspended 
in a solution of bovine albumin, 0.75%, with antibiotics (100 μg/mL 
of streptomycin and 100 UI/mL of penicillin) and centrifuged at 6,000 
rpm for 20 minutes. 0.02 mL/mouse of each suspension was inoculated 
by the intracerebral route in six suckling mice. Blood samples or serum 
were inoculated separately, pure or diluted (50%) in albumin solution. 
The animals were observed for 14 days.
Virus isolation in cell culture: The same suspensions of tissues 
for inoculation in mice, in addition to blood and serum, were also 
subjected to isolation of the virus in Aedes albopictus cell culture, clone 
C6/3617, and indirect immunofluorescence assay (IFA), following the 
technique standardized by GUBLER et al.12. Polyclonal anti-yellow fever 
antibodies, prepared in mice and anti-mouse immunoglobulin combined 
and marked with fluorescein isothiocyanate (Sigma), were used. The 
positive samples were identified by IFA with YFV monoclonal antibodies 
(Biomanguinhos-RJ)).
RNA extraction and RT-PCR: Total RNA was extracted using 
commercial kits. For tissue fragments the QIAamp ® RNA Blood (Qiagen 
Inc., Ontario, CA) was used, and for serum, the QIAamp ® Viral RNA 
Kit (Qiagen Inc., Ontario, CA) was used, following the manufacturer´s 
instructions. The amplification of viral RNA was performed by one-step 
reverse transcriptase (RT-PCR), followed by a second amplification 
(semi-nested)9 from the products of the first reaction, diluted at 1:50. The 
amplified products were visualized by electrophoresis in 1.5% agarose 
gel stained with ethidium bromide. Positive samples were those that had 
a band compatible with the expected.
Sequencing: The positive samples were sequenced directly on an 
ABI 377 sequencer by method of termination dideoxy cycle sequence, 
using the BigDye Terminator sequencing kit v.3.1 (Applied Biosystems, 
Foster City, CA), following the instructions recommended by the 
manufacturer with the same pair of primers of RT-PCR reaction in one 
step. For the edition of the nucleotide sequences, Chromas EditSeq 1.45 
software (Lasergene DNAStar Inc.) was used, excluding the sequences 
of primers. 
Histopathology and Immunohistochemistry: Viscera samples to be 
used for a pathological and immunohistochemical studies, were subjected 
to histological procedures for paraffin inclusion. Slides with histological 
sections obtained from specimens were submitted to histological (by 
hematoxylin-eosin staining) and immunohistochemical analysis. For 
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the immunohistochemical investigation of viral antigen, the polyclonal 
anti-YFV antigen amplified in reaction with the polymer-conjugated 
enzyme (EnvisionTM System- HRP, Dako Cytomation, USA) was used 
and revealed with diaminobenzidine6,33.
Epidemiological analysis: The cases were described according 
to time, place and species/genus. Geographic clusters of cases were 
analyzed separately. 
Expansion of YF vaccination area: All municipalities that had 
identified confirmed cases of YF in NHP passed through a vaccination 
campaign of the human population. Municipalities located inside in a 
radius of 30 km of municipalities with confirmed cases for YF were also 
included in the campaign. 
RESULTS
Ninety-one epizootic events (suspected cases) were registered during 
the study period, amounting to 147 animals, distributed in 36 different 
counties. Figure 1 shows the frequency of notifications per month.
It is observed that the largest number of reported epizootics occurred 
in March and April, 2009, the same period when 28 human cases were 
confirmed in the State (Fig. 1). 
At least, one type of sample from each of the 66 (45%) NHPs was 
collected; 57 (39%) had organ fragments collected, 39 (27%) had blood 
samples taken and 20 (14%) had brain samples collected. 
Among all the animals stated, 67 (45%) were Alouatta spp., 58 
(39%) Callithrix spp., 15 (10%) Sapajus spp. and 7 (6%) of other genus.
Figure 2 shows the geographical distribution of the suspected 
epizooties notified. Two main geographic clusters of notifications could 
be observed - one situated in the north of the State, in an area with 
indication for YF vaccination, and the other one in the south, in a region 
without any indication for YF vaccination until 2009. 
Figure 3 shows the epidemic curves of YF notifications for these 
two clusters. In the cluster area without YF vaccination until 2009, two 
epizootic events were laboratorially confirmed for YF. The first one was 
positive by RT-PCR and virus isolation in mice, from a blood sample 
taken from one animal. Another 45 animals were related, geographically 
and temporally, to this event and case confirmation was made by 
clinical-epidemiological linkage. The second one was confirmed by 
a immunohispathological test, performed on a pool of visceral organs 
of one animal. Another three animals were related, geographically and 
temporally to this event. In this case, confirmation was carried out using 
clinical-epidemiological linkage. All 50 YF confirmed animals were of 
Alouatta spp. genus.
These epizootics enabled the delineation of the new expanded YF 
vaccination indicated area in the State (Fig. 2), within the YF human cases 
surveillance system as well as eco-epidemiological evaluations. In total, 
49 counties were included in the YF risk area and more than one million 
people in the region were vaccinated by the end of 2009.
DISCUSSION
The collection of biological samples and the identification of 
NHP species are limiting factors for surveillance since such events are 
dependent on the availability of trained technicians, who oftentimes 
cannot be available. This demonstrates the need for the periodic 
Fig. 1 - NHPs epizootics notified distribution per month. September 2008, August 2009, 
São Paulo State, Brazil.
Fig. 2 - Geographical distribution of NHPs YF suspected epizooties notified. São Paulo State, 
Brazil, September 2008 to August 2009.
Fig. 3 - Distribution of two main clusters of NHPs epizooties considered suspected cases of 
YF per month. São Paulo State, Brazil, September 2008 to August 2009.
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capacitation on primatology for health professionals involved with 
sample collection in the NHP epizootics surveillance system. This type 
of information would permit important conclusions about the role of 
each species on the eco-epidemiology of YF, as well as the impact of 
the disease in these populations.
Studies strongly rely on epidemics being disclosed by a local rural 
population, since the notifications are made by them. People who have 
experienced epidemics of YF in their regions in the past, are more 
sensitive to these events3. However, results do not represent all NHP 
deaths in the State. 
The two main geographic clusters of epizootic events showed two 
distinct moments for NHP epizootics surveillance in the state of São 
Paulo. Cluster A was situated in the North of State. This region has had 
YF vaccination indicated since 1986 with good vaccine coverage26. In 
the beginning of 2008, YF cases were registered in NHPs and humans 
in the region, and so the vaccination campaigns were intensified. This 
study period coincides with the first rainy season after which higher 
occurrences of YF are expected36. 
Thus, despite the geographic clustering of NHP death notifications 
in the region, they were distributed evenly and in low levels during the 
period studied, characterizing a non epizootic behavior. Notifications 
from this geographical cluster registered three different genera of NHPs: 
Callithix spp., Sapajus spp. and Allouatta spp. However, no sample had 
positive results for YFV. 
Cluster B was located in the southwestern region of the State. The 
region had not had a vaccination program against YF prior to March 2009. 
An increase in the number of notifications, geographic and temporally 
clustered, was detected affecting individuals of the same genus (Howler 
monkey - Alouatta spp.), in a short period of time, thus characterizing 
an epizootic behavior. 
In this cluster only Alouatta deaths were notified. The same genus 
was also shown in studies conducted in other parts of Brazil3,11 as well 
as in the north of Argentina14 in the same period.
Howler monkeys are distributed in neotropical regions, and are 
reported from the state of Vera Cruz in Mexico to the state of Rio Grande 
do Sul in Brazil, and Corrientes in Argentina11. In São Paulo State the 
two species of howler monkeys most commonly registered are: A. caraya 
and A. clamitans. 
A. caraya occurs in the north and northwest regions in areas composed 
of savanna-like vegetation while A. clamitans occurs particularly in the 
south, southeast and coastal zones of the state in areas composed of 
rainforest vegetation. The lack of information about the size of Alouatta 
spp. populations in the state makes it difficult to estimate the YF impact 
for this species in the region.
Studies such as this present one raise the discussion of the role of 
the impact of emerging infectious diseases on population dynamics of 
its sylvatic hosts, mainly if they are a threatened species, which can 
potentially cause secondary effects in the whole ecosystem2,22.
In simple parasite-hosts systems, the pathogens would not cause the 
extinction of their hosts, because over time the virulence of the pathogens 
is expected to attenuate2. If this attenuation does not take place, the 
population of the host can be reduced to very low levels. 
Alternatively, a pathogen can lead to the extinction of a host. In this 
case, its impact reduces the host’s population to such low levels that it 
makes it vulnerable to stochastic events21.
The prevalence of diseases transmitted by vectors, such as YF, with 
a wide range of host species is less dependent on a hosts density than 
on its diversity. The presence of many possible reservoir species (wild 
mosquitoes of genus Haemagogus spp. and Sabhetes spp.)4, or hosts 
species with different levels of susceptibility (Sapajus spp., Callitrhix 
spp., Allouatta spp., Homo sapiens) can increase the environmental viral 
charge and be a source of infection for sensitive species.
The dilution effect can explain this system. This effect is reached 
when, in a given place, vertebrate host species with low capacity of infect 
their vectors share the same environment, diluting the effect of highly 
competent reservoir species34. For YFV, the contribution of each species 
potentially involved in its epidemiological cycle is not totally known. 
The combination of different species in a certain area makes it possible 
for different capacities to increase the viral load level in the environment.
Moreover, it is known that fragmented environments tend to posse 
less species diversity, potentially leading to a reduction in the dilution 
effect for viruses such as YFV. This fragmentation can lead to a further 
increase of the rate of encounters among pathogenic agents and their 
reservoirs, vectors and host species. As a consequence, there is an increase 
in environmental agent charge in a reduced space of time, which works 
as a catalyst for this system. This would favor the occurrence of more 
explosive outbreaks in sensitive populations, which is particularly the 
case with Howler monkeys.
Species of the Sapajus spp. genus are easily infected by YFV. 
However, they show low rates of lethality as, in general, this species 
acquires immunity. In laboratory conditions, they respond to YFV 
inoculation with two to six days of viremia. They can serve as blood 
meals for mosquitoes for a considerable period of time thus suggesting 
an amplificatory role of these species in the YFV cycle13.
Due to a high sensibility and susceptibility to the infection with 
YFV, Howler monkeys succumb quickly to the disease, presenting an 
extremely acute pattern1,14,27,28,30. Considering the reduced time of viremia 
and exposure to vectors, they can be considered as the final hosts of the 
disease.
Humans, with an incidence rate of asymptomatic cases that can reach 
up to 70% 34,36, could have a more important role as YFV amplifier hosts 
than NHP primate species in some regions affected by YF34. As a result, 
the vaccination of human populations, that surround areas with known 
susceptible populations of Howler monkeys, could have some impact in 
the conservation of these species.
Although these epizootic events didn’t work as sentinel for the 
detection of YF human cases in the studied region, they were an 
important tool for the redefinition of the area of YF risk in the state. 
The NHP Epizootic Surveillance System also contributed indirectly 
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to our knowledge about the distribution of NHPs species in São Paulo 
State, Brazil, as well as to the potential impact of YF in Howler monkey 
populations in Brazil. In conclusion, Yellow fever caused at least two 
epizootic events affecting 50 animals of Alouatta spp. genus in São Paulo 
State, Brazil, in the period between September 2008 and August 2009. 
The Non Human Primate Epizootic Surveillance System was shown to 
be an important tool for the YF control, being vital in defining risk areas 
and identifying human and NHP vulnerable populations. The paper also 
demonstrated the importance of descriptive epidemiology supporting an 
evidence-based public-health decision-making process to guide actions 
in YF outbreak emergency situations.
RESUMO
Epizootias de febre amarela em primatas não humanos no estado 
de São Paulo, Brasil, 2008-2009
Desde 2000, vem sendo observada a expansão da febre amarela (FA) 
no Sudeste do Brasil, sendo detectados casos em áreas consideradas 
silenciosas por décadas. Epizootias em primatas não humanos (NHPs) 
são considerados eventos sentinela para a detecção de casos humanos. 
É importante relatar eventos epizoóticos que podem ter impacto sobre o 
estado de conservação de espécies sensíveis. Descrevemos as epizootias, 
notificadas em NHPs no estado de São Paulo, Brasil, entre setembro de 
2008 a agosto de 2009. Noventa e um eventos epizoóticos, envolvendo 
147 animais, foram notificados em 36 municípios. As amostras foram 
obtidas a partir de 65 animais (44,2%). A maioria das epizootias (46,6%) 
foram registradas entre março e abril, no mesmo período no qual YF em 
que casos humanos ocorreram no estado. As amostras biológicas foram 
coletadas de animais encontrados mortos e enviadas ao Instituto Adolfo 
Lutz, em São Paulo. Duas amostras, coletadas em dois municípios, sem 
indicação para a vacinação de febre amarela, foram positivos para o 
vírus. Outros 48 animais foram associados com FA por vínculo clínico-
epidemiológico com casos confirmados laboratorialmente. Devido 
a doença em humanos e NHPs terem ocorrido no mesmo período, a 
detecção do vírus em NHPs não funcionou como sentinela, mas ajudou 
no processo de delimitação de novas áreas de risco.
ACKNOWLEDGMENTS
We are grateful to Marcia Cristina T. Silva for supplying the cell 
culture and to Lucy T.A. dos Santos and Regina C.W.F Mozetic for 
supplying the suckling mice.
REFERENCES
 1.  Aguiar LM, Mellek DM, Abreu KC, Boscarato TG, Berbardi IP, Miranda JMD, et 
al. Sympatry between Alouatta caraya and Alouatta clamitans and the rediscovery 
of free ranging potential hybrids in Southern Brazil. Primates. 2007;48:245-8.
 2.  Anderson RM. Parasite pathogenicity and the depression of host population equilibria. 
Nature. 1979;279:150-2.
 3.  Bicca-Marques JL, Freitas DS. The role of monkeys, mosquitoes, and humans in the 
occurrence of a yellow fever outbreak in a fragmented landscape in south Brazil: 
protecting Howler monkeys is a matter of public health. Trop Conserv Sci. 2010;3:78-
89.
 4.  Bush AO, Lafferty KD, Lotz JM, Shostak AW. Parasitology meets ecology on its own 
terms: Margolis et al. J Parasitol. 1997;83:575-83.
 5.  Brés PLJ. A century of progress in combating yellow fever. Bull World Health Organ. 
1986;64:775-86.
 6.  Brito T, Siqueira AS, Santos RT, Nasser ES, Coimbra TL, Alves VA. Human fatal 
yellow fever. Immunohistochemical detection of viral antigens in liver, kidney and 
heart. Pathol Res Pract. 1992;188(1-2):177-81.
 7.  Bryant J, Wang H, Cabezas C, Ramírez G, Watts D, Russell K, et al. Enzootic 
transmission of yellow fever virus in Peru. Emerg Infect Dis. 2003;9:926-33.
 8.  Câmara FP, Gomes ALBB, Carvalho LMF, Castello LGV. Dynamic behavior of 
sylvatic yellow fever in Brazil (1954-2008). Rev Soc Bras Med Trop. 2011;44:297-9.
 9.  Deubel V, Huerre M, Cathomas G, Drouet MT, Wuscher N, Le Guenno B, et al. 
Molecular detection and characterization of yellow fever virus in blood and liver 
specimens of a non-vaccinated fatal human case. J Med Virol. 1997;53:212-7.
 10.  Formenty P, Boesch C, Wyers M, Steiner C, Donati F, Dind F, et al. Ebola virus 
outbreak among wild chimpanzees living in a Rain Forest of Côte d’Ivoire. J Infect 
Dis. 1999;179(Suppl 1):120-6.
 11.  Gregorin R. Taxonomia e variação geográfica das espécies do gênero Alouatta 
Lacépède (Primates, Atelidae) no Brasil. Rev Bras Zool. 2006;23:64-144.
 12.  Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A. Mosquito cell cultures and 
specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med 
Hyg. 1984;33:158-65
 13.  Hervé JP, Dégallier N, Travassos da Rosa APA, Sá Filho GC. A febre amarela silvestre 
no Brasil e os riscos de propagação urbana. Hiléia Méd. 1985;7:31-40.
 14.  Holzmann I, Agostini I, Areta JI, Ferreyra H, Beldomenico P, Di Bitetti MS. Impact of 
yellow fever outbreaks on two Howler monkey species (Alouatta guariba clamitans 
and A. caraya) in Misiones, Argentina. Am J Primatol. 2010;72:475-80. 
 15.  Hutin YJF, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, et al. Outbreak 
of human monkeypox, Democratic Republic of Congo, 1996-1997. Emerg Infect Dis. 
2001;7:434-8.
 16.  IBGE - Instituto Brasileiro de Geografia e Estatística. Censo 2010. [Cited: 2011 
June]. Available from: http://www.censo2010.ibge.gov.br
 17.  Igarashi A. Isolation of Singh´s Aedes albopictus cell line clone sensitive to dengue 
and chikungunya virus. J Gen Virol. 1978;40:531-44.
 18.  Informe Técnico Centro de Vigilância Epidemiológica de São Paulo (CVE). 2009. 
Febre amarela silvestre no Estado de São Paulo, 2009. [Cited: 2011 June]. Available 
from: ftp://ftp.cve.saude.sp.gov.br/doc_tec/ZOO/Boletim_FASP171209.pdf
 19.  IUCN. IUCN Red List of Threatened Species. 2009. [Cited 2011 June]. Available 
from: www.iucnredlist.org 
 20.  Lima MA, Romano-Lieber NS, Duarte AMRC. Circulation of antibodies against 
yellow fever virus in a simian population in the area of Porto Primavera Hydroelectric 
Plant, São Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2010;52:11-5.
 21.  Lima MR. Effects of infectious diseases and parasites on host populations and natural 
communities: the use of non-indigenous species (NIS) as models. Oecologia Australis. 
2010;14:766-83.
 22.  McCallum H, Dobson A. Detecting disease and parasite threats to endangered species 
and ecosystems. Trends Ecol Evol. 1995;10:190-4. 
 23.  Ministério da Saúde. Secretaria de Vigilância em Saúde. Manual de vigilância de 
epizootias em primatas não-humanos/Ministério da Saúde, Secretaria de Vigilância 
em Saúde – Brasília. 2005. [Cited 2011 June]. Available from: http://portal.saude.
gov.br/portal/arquivos/pdf/epizootias.pdf
MORENO, E.S.; SPINOLA, R.; TENGAN, C.H.; BRASIL, R.A.; SICILIANO, M.M.; COIMBRA, T.L.M.; SILVEIRA, V.R.; ROCCO, I.M.; BISORDI, I.; SOUZA, R.P.; PETRELLA, S.; 
PEREIRA, L.E.; MAEDA, A.Y.; SILVA, F.G. & SUZUKI, A. - Yellow fever epizootics in non-human primates, São Paulo State, Brazil, 2008-2009. Rev. Inst. Med. Trop. Sao Paulo, 
55(1): 45-50, 2013. 
50
 24.  Ministério da Saúde/Secretaria de Vigilância em Saúde. Emergências em Saúde 
Pública de Importância Nacional (ESPIN) de Febre Amarela Silvestre em São Paulo 
e no Rio Grande do Sul e a Situação Epidemiológica Atual no Brasil (2008/2009). 
2009. [Cited: 2011 June]. Available from: http://portal.saude.gov.br/portal/arquivos/
pdf/boletim_febre_amarela_09_12_09.pdf 
 25.  Ministério da Saúde - Secretaria de Vigilância em Saúde. Guia de Vigilância 
Epidemiológica. Série A. Normais e Manuais Técnicos. Brasília – DF. 2009. [Cited 
2011 June]. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/Guia_Vig_
Epid_novo2.pdf 
 26.  Ministério da Saúde, Secretaria de Vigilância em Saúde. Boletim Eletrônico 
Epidemiológico, Situação Epidemiológica das Zoonoses de Interesse à Saúde Pública. 
2009. [Cited: 2011 June]. Available from: http://portal.saude.gov.br/portal/arquivos/
pdf/ano09_n01_sit_epidemiol_zoonoses-br.pdf 
 27.  Moreno ES, Rocco IM, Bergo ES, Brasil RS, Siciliano MM, Suzuki A, et al. 
Reemergence of yellow fever: detection of transmission in the State of São Paulo, 
Brazil, 2008. Rev Soc Bras Med Trop. 2011;44:290-6.
 28.  Ott-Joslin JE. Viral diseases in nonhuman primates. In: Fowler M. Zoo and wild 
animal medicine. Philadelphia: W.B. Saunders; 1986. p. 674-97.
 29.  Rawlins SC, Hull B, Chadee DD, Martinez R, Lemaitre A, James F, Webb L. 
Sylvatic yellow fever activity in Trinidad, 1988-1989. Trans R Soc Trop Med Hyg. 
1990;84:142-3.
 30.  Rede Nacional de Combate ao Tráfico de Animais Silvestres 2008. 1º Relatório 
Nacional sobre o Tráfico de Fauna Silvestre. [Cited: 2011 June]. Available from: 
www.renctas.org.br
 31.  Richter CB, Lehner NDM, Henrickson RV. Primates. In: Fox JG, Cohen BJ, Loew 
FM, editors. Laboratory animal medicine. San Diego: Academic Press; 1984. p. 
287-383.
 32.  Rifakis PM, Benitez JA, Pineda JP, Rodriguez-Morales A. Epizootics of yellow 
fever in Venezuela (2004-2005) an emerging zoonotic disease. Ann N Y Acad Sci. 
2006;1081:57-60.
 33.  Rylands AB, Mittermeier RA. The diversity of the new world primates (Platyrrhini): 
an annotated taxonomy. In: Garber PA, Estrada A, Bicca-Marques IC, Heymann EK, 
Strier KB, editors. South American primates: comparative perspectives in the study 
of behavior, ecology, and conservation. New York: Springer; 2009. p 23-54. 
 34.  Sabbatini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, et al. The 
EnvisionTM + System: a new immunohistochemical method for diagnostics and 
research. Critical comparison with the APAAP, ChemMateTM, CSA, LABC and 
SABC techniques. J Clin Pathol. 1998;51:506-11.
 35.  Souza RP, Foster PG, Sallum MAM, Coimbra TLM, Maeda AY, Silveira VR, et al. 
Detection of a new yellow fever virus lineage within the South American genotype 
I in Brazil. J Med Virol. 2010;82:175-85.
 36.  Thompson SA, Hilliard JK, Kittel D, Lipper S, Giddens WE, Black DH, et al. 
Retrospective analysis of an outbreak of B virus infection in a colony of DeBrazza’s 
monkeys (Cercopithecus neglectus). Comparative Med. 2000;50:648-57.
37.  Vasconcelos PFC. Febre amarela. Rev Soc Bras Med Trop. 2003;36:275-93.
Received: 27 March 2012
Accepted: 16 July 2012
